Include These Five Nutritious Dishes In Your Meals To Aid Weight Loss

Include These Five Nutritious Dishes In Your Meals To Aid Weight Loss

Your diet does not necessarily need to undergo major changes, but you need to make a few healthy choices for food

A subtle tweak, like introducing a high-protein and fibre-rich diet and reducing the intake of carbohydrates, can help in losing weight

A healthy diet and a few lifestyle changes could help you achieve your weight loss goal faster. To shed those extra kilos, you have to be mindful of your diet and physical exercise routine. It may sound challenging at first, but gradually, you will get used to it. Your diet does not necessarily need to undergo major changes, but you need to make a few healthy choices for food.

A subtle tweak, like introducing a high-protein and fibre-rich diet and reducing the intake of carbohydrates, can help with your weight loss journey.

Here are 5 nutritious meals that may aid in weight loss:

Veggies and Hummus sandwich

A veggie and hummus sandwich makes a great fibre-rich lunch. Hummus is a spread or a dip that is made from cooked and mashed chickpeas blended with tahini, garlic, olive oil, lemon juice and salt. You can pair it with any kind of bread or use it in sandwiches. Take a few slices of multi-grain bread and spread the hummus on all the slices. Add the vegetables like bell pepper, cucumber, lettuce, onion, and tomato slices to make a delicious sandwich.

Oats Khichdi

We all know that oats are healthy and should be a part of our regular diet. You can either eat it as porridge or just make a khichdi out of it. You can add dal and vegetables to make it healthier. Just add chopped carrots, onions, cauliflower, tomatoes, french beans and a few chillies. For extra flavour you can add garlic as well.

Upma

Upma is a flavourful and healthy dish that you can cook in a jiffy. It is a perfect meal option made of lightly roasted semolina, green peas, carrot and onions and lightly tempered with mustard seeds and curry leaves. Green Peas are high in protein content and low in calories. It is loaded with vitamins K and C, manganese and fibre.

Oats dosa

Switch the rice ingredient with oats and you can cut down on your carbs intake. Unlike typical dosa, oats do not need to be soaked. You can add soaked urad dal in a small quantity with oats for binding. Make a batter blending the urad dal and oats together. Let it ferment for 10-12 hours. You can make oats dosas and pair it with sambar and coconut chutney.

Besan Chilla

Besan Chilla is made with gram flour (besan), onions, tomatoes, herbs and spices. You can add finely chopped or grated vegetables to increase the nutrition of the dish. Have it for your breakfast or lunch .

Read all the Latest Lifestyle News here

Researchers discover therapeutic target to aid in glaucoma treatment

Researchers discover therapeutic target to aid in glaucoma treatment
hRGCs maintain mitochondrial mass by simultaneous degradation and biogenesis of mitochondria under damage. a, b Representative confocal immunofluorescence images of H7-hRGCs against mitochondrial Tom20, tdTomato, and DAPI after indicated 10 μM CCCP treatment timepoints. Scale bars are 5 μm. c, d Quantification of Tom20 intensity per cell area from sum projections of confocal z-stacks, normalized to corresponding DMSO. n = 14–42 cells per condition. e, f Mitochondrial DNA copy number analyzed by qPCR for mitochondrial ND1 gene relative to nuclear RNase P. Results shown as ΔΔCt fold changes relative to DMSO control for different times points of 10 μM CCCP treatment. n = 3, 3 technical repeats averaged for each biological repeat. g Schematic of MTDR flow experiments for tracking degrading versus newly synthesized mitochondria. h Mitochondrial mass in single cells at different CCCP (10 μM) treatment time points for degradation or m different timepoints post CCCP (10 μM) wash for biogenesis were measured by flow cytometer, and the average fluorescence intensity normalized to DMSO was plotted. n = 3. i, k Representative western blot images of LC3B and actin from i hRGCWT and k hRGCE50K treated with CCCP (10 μM) for the indicated timepoints. j, l Quantification of the ratio of LC3B-II to corresponding LC3B-I for each condition. n = 3. ٭p-value < 0.05, ٭٭p-value < 0.01, ٭٭٭p-value < 0.001, ٭٭٭٭p-value < 0.0001. Unpaired student’s t-test between independent datasets. Error bars are SEM. Credit: Communications Biology (2023). DOI: 10.1038/s42003-023-04576-w

Indiana University School of Medicine researchers have identified a new therapeutic target that could lead to more effective treatment of glaucoma.

Glaucoma is a neurodegenerative disease that causes vision loss and blindness due to a damaged optic nerve. More than 200,000 people are affected by glaucoma in the United States each year. Unfortunately, there is currently no treatment. In a newly published paper in Communications Biology, researchers found neurons use mitochondria for a steady source of energy, and restoring mitochondrial homeostasis in the diseased neurons can protect the optic nerve cells from being damaged.

“Age-related neurodegenerative disease, which includes glaucoma, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS), is the biggest global health problem,” said Arupratan Das, Ph.D., assistant professor of ophthalmology and principal investigator of the study.

“The fundamental mechanisms that we discovered can be used to protect neurons in glaucoma and be tested for the other diseases. We have identified a critical step of complex mitochondrial homeostasis process, which rejuvenates the dying neuron, similar to giving a lifeline to a dying person.”

The research team, led by Michelle Surma and Kavitha Anbarasu from the Department of Ophthalmology, used induced pluripotent stem cells (iPSCs) from patients with and without glaucoma as well as clustered regularly interspaced short palindromic repeats (CRISPR) engineered human embryonic stem cells with glaucoma mutation.

Using stem cell differentiated retinal ganglion cells (hRGCs) of the optic nerve, electron microscopy and metabolic analysis, researchers identified glaucomatous retinal ganglion cells suffer mitochondrial deficiency with more metabolic burden on each mitochondrion. This leads to mitochondrial damage and degeneration. Mitochondria are the tube like structures in cells which produce adenosine triphosphate, cell’s energy source.

However, the process could be reversed by enhancing mitochondrial biogenesis by a pharmacological agent. The team showed retinal ganglion cells are highly efficient in degrading bad mitochondria, but at the same time producing more to maintain homeostasis.

“Finding that retinal ganglion cells with glaucoma produce more adenosine triphosphate even with less mitochondria was astonishing,” Das said. “However, when triggered to produce more mitochondria, the adenosine triphosphate production load was distributed among more mitochondrion which restored the organelle physiology. It is similar to a situation where a heavy stone is carried by fewer people versus a greater number of people—each person will have less pain and injury, just like each mitochondrion will have less difficulty and damage.”

In the future, Das would like to test if these mechanisms protect the optic nerve in animal models under injury before testing in humans to hopefully lead to new clinical interventions.

More information:
Michelle Surma et al, Enhanced mitochondrial biogenesis promotes neuroprotection in human pluripotent stem cell derived retinal ganglion cells, Communications Biology (2023). DOI: 10.1038/s42003-023-04576-w

Provided by
Indiana University School of Medicine


Citation:
Researchers discover therapeutic target to aid in glaucoma treatment (2023, March 10)
retrieved 11 March 2023
from https://medicalxpress.com/news/2023-03-therapeutic-aid-glaucoma-treatment.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

People with diabetes struggle to find Ozempic as it soars in popularity as a weight loss aid

Tammie Rachell Largent-Phillips, 52, has Form 2 diabetes. For the earlier two years, she’s managed the situation using a drug termed Ozempic, which will help men and women with diabetic issues preserve blood sugar concentrations in check.

But in November, she was pressured to swap to a different medication, insulin. The Ozempic she wanted was no for a longer period offered at her pharmacy.

In current months, demand for the drug has soared, colliding with global supply problems. Jointly, it really is led to a lack of Ozempic.

But the level of popularity of Ozempic, or semaglutide, is just not because of climbing charges of diabetic issues. As a substitute, it is really mainly because of its weight reduction added benefits, physicians say. At a higher dose, semaglutide is made use of for weight decline. Ozempic manufacturer Novo Nordisk sells that increased dose under a various brand identify: Wegovy.

Shortages of Wegovy, also highly common, ended up widespread very last calendar year. As a outcome, some persons who experienced been using Wegovy were being as a substitute approved Ozempic off-label for pounds loss. That’s triggering challenges for men and women like Largent-Phillips, who will need the drug to deal with their persistent disease.

“It is been quite frustrating,” Largent-Phillips, of Florida, said of the shortage, adding that her blood sugar stages have been fluctuating as she’s experienced to transform remedies.

In people today with Style 2 diabetic issues, the human body doesn’t use insulin properly. Insulin is a hormone that tells cells in the overall body to take up glucose, or sugar, from the blood. If the body isn’t going to use it perfectly, that sugar stays in the blood, resulting in significant blood sugar levels.

Ozempic works by mimicking a hormone in the human body that regulates insulin stages. It can be a type of drug termed a GLP-1 agonist. The medication is self-administered weekly as an injection.

Without treatment, folks with Type 2 diabetic issues danger blood sugar spikes that can likely direct to major health and fitness issues, like heart ailment, kidney disorder, listening to reduction and stroke.

“Even in the quick run, people can come to feel inadequately from large blood glucose stages,” mentioned Dr. Robert Gabbay, chief scientist for the American Diabetic issues Affiliation.

The offer shortages of Ozempic have meant that some individuals have experienced to go to numerous pharmacies ahead of they could come across the medicine, mentioned Dr. Marcio Griebeler, an endocrinologist at the Cleveland Clinic in Ohio. In other situations, he claimed, sufferers have been compelled to take a reduced dose simply because it really is all that was out there.

That’s not “great,” Griebeler stated, mainly because clients may not respond the exact same way as they did on the bigger dose.

For all those who can not obtain the drug at all, the only option is to swap to a further medicine, which might not be as productive, explained Dr. Susan Spratt, an endocrinologist and senior health-related director for the Inhabitants Health and fitness Administration Workplace at Duke Wellbeing in North Carolina. 

That is what Shane Anthony, 57, of Seattle, has had to do. He has Style 2 diabetic issues and has not been in a position to get Ozempic given that Oct.

Anthony was recommended a distinctive treatment, but he explained it’s not as productive. His wife, Gerilynn, who is a nurse, claimed his blood sugar levels have absent again up because becoming off Ozempic.

“It truly can make me mad it infuriates me,” Anthony explained. “We have to have it to continue to be alive and maintain working on an daily basis.”

Switching to another drug also complicates matters when Ozempic turns into out there all over again.

Likely back on Ozempic is just not generally a straightforward adjustment, Spratt claimed because it can occur with side consequences, these as nausea or vomiting, people are normally first recommended a decreased dose that is steadily increased in excess of several weeks.

“In get to get back again on the drug, you have to commence all above yet again,” she stated, “and that’s definitely burdensome.”

Dr. Disha Narang, an endocrinologist at Northwestern Medicine Lake Forest Hospital in Illinois, reported she sees sufferers “each day” who ended up taking Ozempic and then afterwards located out their pharmacy no for a longer period carried the medication.

Some clients have identified luck discovering samples in doctors’ workplaces, she explained.

But other individuals stopped getting medicine altogether, she explained, major their blood sugar degrees to increase.

The shortage has been rough on both clients and doctors, she additional.

“We don’t automatically have regulate about the supply chain,” she said, adding that doctors act as a sort of intermediary in between sufferers and the remedies they require.

Novo Nordisk, the corporation that would make the two Ozempic and Wegovy, told NBC Information that the availability of Ozempic has enhanced, but offer troubles still continue being.

Allison Schneider, a spokesperson for the company, reported in a statement that Ozempic is at present offered in particular dosages for Form 2 diabetes, on the other hand, the enterprise is nevertheless going through offer difficulties that will final by means of the thirty day period and people in some regions of the U.S. will expertise delays in obtaining their medication.

“Anyone anxious with continuity of cure, should really make contact with their healthcare service provider,” she said.

Largent-Phillips, of Florida — who has been documenting her encounter on TikTok — claimed that for now, she has to be vigilant about checking her blood sugar concentrations.

She explained she would not blame the people today who are employing it for excess weight reduction for the lack, but the producer and offer chain.

She pointed out that there are a whole lot of folks aside from her who need to have this medication to handle their illnesses.

“This is terrible,” she explained.

Follow NBC Well being on Twitter & Facebook.

Mobility Aid Medical Devices Global Market Report 2022:

Dublin, Dec. 30, 2022 (World NEWSWIRE) — The “Mobility Support Health care Products Market – Global Marketplace Dimensions, Share, Developments, Opportunity, and Forecast, 2018-2028: Segmented By Kind (Wheelchairs, Walking Aids, Mobility Lifts, Slings, Tricycles, Mobility Scooters), By Close Consumer, By Area, Forecast & Prospects, 2028” report has been included to ResearchAndMarkets.com’s providing.

World-wide mobility aid health-related units industry is envisioned to develop at a steady price in the course of the forecast period, 2024-2028. Mobility support healthcare gadgets assist the elderly and disabled persons in moving about. Quick technological breakthroughs in the growth of mobility support medical devices are the important variable responsible for its current market growth.

The demand for these units is expanding noticeably amongst the aged populace as they require treatment, safety and ease in shift and transfer, both of those in hospitals and homecare setups. Various initiatives are taken by the governments to enhance recognition about the use of mobility assist professional medical gadgets amongst the inhabitants and several health care enterprises. Other than, bettering health care infrastructure is also a big motive for the advancement in demand of these equipment.

In addition, assistive technologies help in decreasing challenges in performing working day-to-day things to do for aged and disabled populace. As a result, technological enhancements and new item launches by the key gamers functioning in the current market are predicted to build worthwhile progress alternatives above the following several many years.

The world wide mobility assist clinical devices sector is segmented into form, finish consumer, firm, and area. Based on style, wheelchair is predicted to hold the most dominant share during forecast period. Provision of wheelchair enhances the mobility and high quality of life and reduces common difficulties this kind of as tension sores as effectively as assists in improving upon digestion and respiration.

Regionally, North America is predicted to dominate the marketplace in the course of forecast period of time. This is attributed to the presence of very well-founded health care infrastructure alongside with the authorities initiatives with regards to the recognition of mobility help medical equipment. Other than, the rising adoption of highly developed technologies and growing investing for the growth of new items in the area, are the factors for the development in sector share of the location.

Big gamers functioning in the world-wide mobility help medical gadgets market include things like GF Overall health Items, Inc., Invacare Corporation, Pleasure Mobility Goods Corporation, Dawn Medical Constrained, OttoBock Health care GmbH, Permobil AB, Push Healthcare Ltd., Levo AG, Karman Healthcare Inc., and Meyra Wihelm Meyer GmbH & Co Ltd.

Report Scope:

World-wide Mobility Support Professional medical Equipment Market place, By Variety:

  • Wheelchairs
  • Handbook
  • Run
  • Going for walks Aids
  • Canes
  • Crutches
  • Walkers
  • Many others
  • Mobility Lifts
  • Ceiling Lifts
  • Hydraulic Lifts
  • Many others
  • Slings
  • Universal Slings
  • Bathing & Toileting Slings
  • Stand Up Slings
  • Tricycles
  • Manual
  • Powered
  • Mobility Scooters
  • 3-wheel
  • 4-wheel
  • Others

Global Mobility Aid Professional medical Gadgets Industry, By Close Person:

World wide Mobility Assist Medical Gadgets Current market, By Location:

  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • North America
  • United States
  • Mexico
  • Canada
  • South The usa
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Crucial Matters Coated:

1. Product or service Overview

2. Analysis Methodology

3. Government Summary

4. Voice of Shopper

5. World wide Mobility Help Professional medical Devices Sector Outlook

6. Asia-Pacific Mobility Aid Professional medical Units Industry Outlook

7. Europe Mobility Support Health care Devices Industry Outlook

8. North America Mobility Assist Healthcare Units Current market Outlook

9. South The us Mobility Support Healthcare Products Market place Outlook

10. Center East and Africa Mobility Assist Health care Units Marketplace Outlook

11. Industry Dynamics

12. Sector Tendencies & Developments

13. Aggressive Landscape

14. Strategic Suggestions

Businesses Mentioned

  • GF Overall health Items, Inc.
  • Invacare Corporation
  • Delight Mobility Solutions Corporation
  • Sunrise Medical Constrained
  • OttoBock Healthcare GmbH
  • Permobil AB
  • Generate Medical Ltd.
  • Levo AG
  • Karman Healthcare Inc.
  • Meyra Wihelm Meyer GmbH & Co Ltd

For far more details about this report check out https://www.researchandmarkets.com/r/q8d1id

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s top supply for worldwide current market study reports and market information. We give you with the hottest details on worldwide and regional marketplaces, vital industries, the top organizations, new merchandise and the most current tendencies.